MEF2D and acute lymphoblastic leukemia: In this context, the genomic analyses performed by Gu et al. unveil that the B-ALL patients with MEF2D rearranged present the HDAC9 activation[34], so it is possible that TEX41 too plays a key role in the epigenetic mechanisms linked to this molecular activation process.